GlobeImmune Inc. announced that Timothy C. Rodell has resigned his positions as the company's Chief Executive Officer and President but remains on the Board of Directors; C. Jeffrey Dekker has been appointed as the company's President, Secretary and Treasurer and been named to the company's Board of Directors; J. William Freytag, Augustine J. Lawlor, Dan J. Mitchell and S. Edward Torres have resigned from the company's Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5 | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- GBIM Stock
- News GlobeImmune, Inc.
- GlobeImmune Inc. Announces Management and Board Changes